Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. ERS Statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. European Respiratory Society Guidelines for the Diagnosis of Asthma in Adults

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Prenatal tobacco exposure and risk of asthma and allergy outcomes in childhood

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Automated cell differential count in sputum is feasible and comparable to manual cell count in identifying eosinophilia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Real-world evidence: Methods for assessing long-term health and effectiveness of allergy immunotherapy

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  4. European Respiratory Society Guidelines for the Diagnosis of Asthma in Adults

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

INTRODUCTION: Severe eosinophilic asthma is characterised by frequent exacerbations and a relative insensitivity to steroids., Experimentally, smoking may induce eosinophilic airway inflammation, but the impact in patients with severe asthma is not clear.

OBJECTIVE: To investigate the association between smoking exposure in patients with severe asthma, and eosinophilic inflammation and activation, as well as airway autoimmunity and steroid responsiveness.

METHODS: Patients with severe asthma according to ERS/ATS criteria were assessed with sputum samples, analysed by cell differential count, and for the presence of free eosinophil granules (FEGs), autoantibodies against eosinophil peroxidase (EPX) and macrophage receptor with collagenous structure (MARCO). A subgroup of patients with eosinophilic airway inflammation was re-assessed after a 2-weeks course of prednisolone.

RESULTS: A total of 132 severe asthmatics were included in the study; 39 patients (29.5%) had ≥10 pack years of smoking history; 36 (27.3%) were former smokers and 3 (2.3%) current smokers, and 93 (70.5%) had <10 pack years exposure. Eosinophilic airway inflammation was more prevalent among patients with ≥10 pack years (66.7%), compared to patients with <10 pack years (38.7%, p=0.03), as was the level of FEGs (p=0.001) and both anti-EPX and anti-MARCO(p<0.05 and p<0.0001, respectively). Omitting current smokers did not affect these associations. Furthermore, prednisolone reduced, but did not normalise, sputum eosinophils in patients with a ≥10 pack years smoking history.

CONCLUSION: In patients with severe asthma, a former smoking history is associated with eosinophilic airway inflammation and activation, relative insensitivity to steroids, as well as airway autoimmunity.

OriginalsprogEngelsk
TidsskriftThe European respiratory journal
ISSN0903-1936
DOI
StatusUdgivet - 2 mar. 2022

Bibliografisk note

Copyright ©The authors 2022. For reproduction rights and permissions contact permissions@ersnet.org.

ID: 77579477